Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050 · see citing works

Men at risk: occupation and male infertility.

Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,219 · see citing works

Clinical gynecologic endocrinology and infertility

Fritz, M. A., & Speroff, L. (1983) · Cited by 2,104 · see citing works

Polycystic Ovary Syndrome

Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,884 · see citing works

A Survey of the Polycystic Ovary Syndrome in the Greek Island of Lesbos: Hormonal and Metabolic Profile

Diamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6148 · Cited by 1,107 · see citing works

Insulin resistance during puberty: results from clamp studies in 357 children.

Moran, A., Jacobs, D. R., Steinberger, J., Hong, C. P., Prineas, R. J., Luepker, R. V., & Sinaiko, A. R. (1999) · Diabetes · doi:10.2337/diabetes.48.10.2039 · Cited by 869 · see citing works

Clinical Gynecologic Endocrinology and Infertility

Gussi, I. (2005) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2005.240 · Cited by 766 · see citing works

Classification and pharmacology of progestins

Schindler, A. E., Campagnoli, C., Druckmann, R. A., Huber, J. C., Pasqualini, J. R., Schweppe, K.-W., & Thijssen, J. H. H. (2003) · Maturitas · doi:10.1016/j.maturitas.2003.09.014 · Cited by 741 · see citing works

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment

DeUgarte, C. M., Bartolucci, A. A., & Azziz, R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.070 · Cited by 589 · see citing works

Adolescent Girls with Polycystic Ovary Syndrome Have an Increased Risk of the Metabolic Syndrome Associated with Increasing Androgen Levels Independent of Obesity and Insulin Resistance

Coviello, A. D., Legro, R. S., & Dunaif, A. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1666 · Cited by 446 · see citing works

Induction of insulin resistance by androgens and estrogens

Polderman, K. H., Gooren, L. J., Asscheman, H., Bakker, A., & Heine, R. J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027240 · Cited by 382 · see citing works

Association between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis

Baillargeon, J., McClish, D. K., Essah, P. A., & Nestler, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1958 · Cited by 298 · see citing works

Acne

James, W. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp033487 · Cited by 268 · see citing works

The evaluation and management of hirsutism*1

Azziz, R. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02725-4 · Cited by 247 · see citing works

Endocrine and Metabolic Effects of MetforminVersusEthinyl Estradiol-Cyproterone Acetate in Obese Women with Polycystic Ovary Syndrome: A Randomized Study1

Morin-Papunen, L. C., Vauhkonen, I., Koivunen, R. M., Ruokonen, A., Martikainen, H. K., & Tapanainen, J. S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6792 · Cited by 239 · see citing works

Polycystic ovary syndrome and cancer

Balen, A. (2001) · Human Reproduction Update · doi:10.1093/humupd/7.6.522 · Cited by 216 · see citing works

Long-Term Testosterone Administration Increases Visceral Fat in Female to Male Transsexuals1

Elbers, J. M. H., Asscheman, H., Seidell, J. C., Megens, J. A. J., & Gooren, L. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4078 · Cited by 214 · see citing works

Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial

Vexiau, P., Chaspoux, C., Boudou, P., Fiet, J., Jouanique, C., Hardy, N., & Reygagne, P. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04798.x · Cited by 195 · see citing works

MetforminVersusEthinyl Estradiol-Cyproterone Acetate in the Treatment of Nonobese Women with Polycystic Ovary Syndrome: A Randomized Study

Morin-Papunen, L. C., Vauhkonen, I., Koivunen, R. M., Ruokonen, A., Martikainen, H. K., & Tapanainen, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020997 · Cited by 182 · see citing works

Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone

van der Vange, N., Blankenstein, M. A., Kloosterboer, H. J., Haspels, A. A., & Thijssen, J. H. H. (1990) · Contraception · doi:10.1016/0010-7824(90)90034-s · Cited by 175 · see citing works

Ethinylestradiol-Drospirenone, Flutamide-Metformin, or Both for Adolescents and Women with Hyperinsulinemic Hyperandrogenism: Opposite Effects on Adipocytokines and Body Adiposity

Ibáñez, L., & de Zegher, F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031281 · Cited by 172 · see citing works

A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive Pills

Diamanti‐Kandarakis, E., Baillargeon, J., Iuorno, M. J., Jakubowicz, D. J., & Nestler, J. E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021528 · Cited by 168 · see citing works

Combined oral contraceptives in the treatment of polycystic ovary syndrome

Vrbíková, J., & Cibula, D. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi005 · Cited by 162 · see citing works

Drospirenone for the Treatment of Hirsute Women with Polycystic Ovary Syndrome: A Clinical, Endocrinological, Metabolic Pilot Study

Guido, M., Romualdi, D., Giuliani, M., Suriano, R., Selvaggi, L. E., Apa, R., & Lanzone, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031158 · Cited by 158 · see citing works

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long‐term oestrogen–progestagen treatment

Pasquali, R., Gambineri, A., Anconetani, B., Vicennati, V., Colitta, D., Caramelli, E., Casimirri, F., & Morselli‐Labate, A. M. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00701.x · Cited by 157 · see citing works

Endocrine and Metabolic Effects of Metformin Versus Ethinyl Estradiol-Cyproterone Acetate in Obese Women with Polycystic Ovary Syndrome: A Randomized Study

Morin-Papunen, L. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3161 · Cited by 157 · see citing works

Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study

Elter, K., İmir, G., & Durmuşoğlu, F. (2002) · Human Reproduction · doi:10.1093/humrep/17.7.1729 · Cited by 152 · see citing works

Metabolic effects of oral contraceptives in women with polycystic ovary syndrome.

Korytkowski, M. T., Mokan, M., Horwitz, M. J., & Berga, S. L. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.11.7593446 · Cited by 140 · see citing works

Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives

Mastorakos, G., Koliopoulos, C., & Creatsas, G. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02993-x · Cited by 137 · see citing works

Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins

Phillips, A., Demarest, K. T., Hahn, D. W., Wong, F. A., & McGuire, J. L. (1990) · Contraception · doi:10.1016/0010-7824(90)90039-x · Cited by 119 · see citing works

Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome

Dahlgren, E., Landin, K., Krotkiewski, M., Holm, G., & Janson, P. O. (1998) · Human Reproduction · doi:10.1093/humrep/13.10.2706 · Cited by 118 · see citing works

The influence of female sex steroids on glucose metabolism and insulin action.

Godsland, I. F. (1996) · PubMed · Cited by 114 · see citing works

Gender Factors Affect Fatty Acids-Induced Insulin Resistance in Nonobese Humans: Effects of Oral Steroidal Contraception

Perseghin, G., Scifo, P., Pagliato, E., Battezzati, A., Benedini, S., Soldini, L., Testolin, G., Maschio, A. D., & Luzi, L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7666 · Cited by 110 · see citing works

Oral contraceptive use and the risk of Type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women

Rimm, E. B., Manson, J. E., Stampfer, M. J., Colditz, G. A., Willett, W. C., ROSNER, B. A., Hennekens, C. H., & Speizer, F. E. (1992) · Diabetologia · doi:10.1007/bf00401427 · Cited by 100 · see citing works

The Effect of a Desogestrel-Containing Oral Contraceptive on Glucose Tolerance and Leptin Concentrations in Hyperandrogenic Women

Nader, S., Riad, M. G., & Saad, M. F. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4192 · Cited by 100 · see citing works

A Prospective Study of Oral Contraceptives and NIDDM Among U.S. Women

Chasan‐Taber, L., Willett, W. C., Stampfer, M. J., Hunter, D. J., Colditz, G. A., Spiegelman, D. L., & Manson, J. E. (1997) · Diabetes Care · doi:10.2337/diacare.20.3.330 · Cited by 88 · see citing works

The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients

Cibula, D., Fanta, M., Vrbíková, J., Stanická, S., Dvorakova, K., Hill, M., Škrha, J., Zivny, J., & Skrenková, J. (2004) · Human Reproduction · doi:10.1093/humrep/deh588 · Cited by 83 · see citing works

SOME EFFECTS OF ORAL CONTRACEPTIVES ON CARBOHYDRATE METABOLISM

Wynn, V., & Doar, J. W. H. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90477-2 · Cited by 78 · see citing works

Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome

Sabuncu, T., Harma, M., Harma, M., Nazligul, Y., & Kilic, F. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)02162-9 · Cited by 78 · see citing works

Treatment of hirsutism with ethinyl estradiol–desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity

Escobar-Morreale, H. F., Lasunción, M. A., & Sancho, J. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00718-4 · Cited by 70 · see citing works

Glucose Metabolism and Insulin Resistance in Women with Polycystic Ovary Syndrome during Therapy with Oral Contraceptives Containing Cyproterone Acetate or Desogestrel

Cagnacci, A., Paoletti, A. M., Renzi, A., Orrù, M., Pilloni, M., Melis, G. B., & Volpe, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030328 · Cited by 69 · see citing works

Flutamide-Metformin Plus Ethinylestradiol-Drospirenone for Lipolysis and Antiatherogenesis in Young Women with Ovarian Hyperandrogenism: The Key Role of Early, Low-Dose Flutamide

Ibáñez, L., Valls, C., Cabré, S., & de Zegher, F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0047 · Cited by 61 · see citing works

Flutamide-Metformin plus Ethinylestradiol-Drospirenone for Lipolysis and Antiatherogenesis in Young Women with Ovarian Hyperandrogenism: The Key Role of Metformin at the Start and after More than One Year of Therapy

Ibáñez, L., & de Zegher, F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1405 · Cited by 60 · see citing works

The Evaluation and Management of Hirsutism

Azziz, R. (2003) · Obstetrics and Gynecology · doi:10.1097/00006250-200305000-00029 · Cited by 59 · see citing works

Effects of long‐term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome

Falsetti, L., & Pasinetti, E. (1995) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349509009945 · Cited by 57 · see citing works

SOME EFFECTS OF ORAL CONTRACEPTIVES ON CARBOHYDRATE METABOLISM

Wynn, V., & Doar, J. W. H. (1967) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-196704000-00039 · Cited by 53 · see citing works

Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin

Cibula, D. (2002) · Human Reproduction · doi:10.1093/humrep/17.1.76 · Cited by 53 · see citing works

An observational study of Yasmin® in the management of women with polycystic ovary syndrome

Palep-Singh, M., Mook, K., Barth, J. H., & Balen, A. H. (2004) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/1471189041261636 · Cited by 51 · see citing works

Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII

van Rooijen, M., von Schoultz, B., Silveira, A. M. V., Hamsten, A., & Bremme, K. A. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.119179 · Cited by 46 · see citing works

Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity

Ibáñez, L. (2004) · Human Reproduction · doi:10.1093/humrep/deh329 · Cited by 44 · see citing works

Effects of Obesity, Glucocorticoid, and Oral Contraceptive Therapy on Plasma Glucose and Blood Pyruvate Levels

Doar, J. W. H., & Wynn, V. (1970) · BMJ · doi:10.1136/bmj.1.5689.149 · Cited by 44 · see citing works

Effects of a 1-year treatment with a low-dose combined oral contraceptive containing ethinyl estradiol and cyproterone acetate on glucose and insulin metabolism

Scheen, A. J., Jandrain, B. J., Humblet, D. M. P., Jaminet, C. B., GASPARD, U. J., & Lefèbvre, P. J. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55862-2 · Cited by 41 · see citing works

Oral contraceptive use and glucose metabolism in a national sample of women in the United States

Troisi, R. J., Cowie, C. C., & Harris, M. I. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.105909 · Cited by 41 · see citing works

Uniqueness of oral contraceptive progestins

Carr, B. R. (1998) · Contraception · doi:10.1016/s0010-7824(98)00079-1 · Cited by 40 · see citing works

Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate

Armstrong, V. (2001) · QJM · doi:10.1093/qjmed/94.1.31 · Cited by 39 · see citing works

Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?

Cibula, D., Hill, M., Fanta, M., Šindelka, G., & Zivny, J. (2001) · Human Reproduction · doi:10.1093/humrep/16.5.940 · Cited by 38 · see citing works

Oral Contraceptives, Tubal Sterilization, and Functional Ovarian Cyst Risk

Holt, V. L., Cushing-Haugen, K. L., & Daling, J. R. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(03)00572-6 · Cited by 34 · see citing works

Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome

Vrbíková, J., Stanická, S., Dvorakova, K., Hill, M., Vondra, K., Bendlová, B., & Stárka, L. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500215 · Cited by 31 · see citing works

Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy

Hammond, G. L., Rabe, T., & Wagner, J. D. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.117415 · Cited by 29 · see citing works

Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives

Petersen, K. R., Christiansen, E., Madsbad, S., Skouby, S. O., Andersen, L. F., & Jespersen, J. (1999) · Contraception · doi:10.1016/s0010-7824(99)00107-9 · Cited by 24 · see citing works

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676 · see citing works

Treatment options for polycystic ovary syndrome

Badawy, A., & Elnashar (2011) · International Journal of Women s Health · doi:10.2147/ijwh.s11304 · Cited by 613 · see citing works

Obesity and Polycystic Ovary Syndrome

Vrbíková, J., & Hainer, V. (2009) · Obesity Facts · doi:10.1159/000194971 · Cited by 237 · see citing works

Hormonal contraceptives: pharmacology tailored to women's health

De Leo, V., Musacchio, M. C., Cappelli, V., Piomboni, P., & Morgante, G. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw016 · Cited by 188 · see citing works

Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis

Bird, S. T., Hartzema, A. G., Brophy, J. M., Etminan, M., & Delaney, J. A. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.120677 · Cited by 126 · see citing works

The effects of old, new and emerging medicines on metabolic aberrations in PCOS

Bargiota, Α., & Diamanti‐Kandarakis, E. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812437355 · Cited by 118 · see citing works

Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome

Cheung, L. P., Ma, R. C. W., Lam, P. M., Lok, I. H., Haines, C. J., So, W. Y., Tong, P. C. Y., Cockram, C. S., Chow, C. C., & Goggins, W. B. (2008) · Human Reproduction · doi:10.1093/humrep/den090 · Cited by 108 · see citing works

Ovarian angiogenesis in polycystic ovary syndrome

Pietro, M. D., Pascuali, N., Parborell, F., & Abramovich, D. (2018) · Reproduction · doi:10.1530/rep-17-0597 · Cited by 98 · see citing works

Therapeutic approach for metabolic disorders and infertility in women with PCOS

Morgante, G., Massaro, M. G., Sabatino, A. D., Cappelli, V., & Leo, V. D. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1370644 · Cited by 94 · see citing works

PCOS in adolescents

Diamanti‐Kandarakis, E. (2009) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2009.09.005 · Cited by 91 · see citing works

Diet and nutrition in polycystic ovary syndrome (PCOS): Pointers for nutritional management

Farshchi, H., Rane, A., Love, A., & Kennedy, R. L. (2007) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610701667338 · Cited by 87 · see citing works

Endometrial Abnormality in Women With Polycystic Ovary Syndrome

Shang, K., Jia, X., Qiao, J., Kang, J., & Guan, Y. (2012) · Reproductive Sciences · doi:10.1177/1933719111430993 · Cited by 87 · see citing works

Long-Term Efficacy and Tolerability of Flutamide Combined with Oral Contraception in Moderate to Severe Hirsutism: A 12-Month, Double-Blind, Parallel Clinical Trial

Calaf, J., López, E., Millet, A. V., Alcañiz, J., Fortuny, A. M. D. L., Vidal, O., Callejo, J., Escobar‐Jiménez, F., Torres, E., & Espinós, J. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2798 · Cited by 80 · see citing works

Metabolic hormones are integral regulators of female reproductive health and function

Athar, F., Karmani, M., & Templeman, N. M. (2023) · Bioscience Reports · doi:10.1042/bsr20231916 · Cited by 76 · see citing works

The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia

Panidis, D., Georgopoulos, N. A., Piouka, A., Katsikis, I., Saltamavros, A. D., Decavalas, G., & Diamanti‐Kandarakis, E. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.507283 · Cited by 71 · see citing works

State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS)

Geller, D. H., Pacaud, D., Gordon, C. M., & Misra, M. (2011) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2011-9 · Cited by 71 · see citing works

Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta-analysis comparing products containing cyproterone acetate with third generation progestins

Amiri, M., Tehrani, F. R., Nahidi, F., Kabir, A., Azizi, F., & Carmina, E. (2017) · Metabolism · doi:10.1016/j.metabol.2017.05.001 · Cited by 70 · see citing works

Metabolic syndrome and polycystic ovary syndrome... and vice versa

Kandaraki, E., Christakou, C. D., & Diamanti‐Kandarakis, E. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200014 · Cited by 67 · see citing works

Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome

Mathur, R. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s6864 · Cited by 64 · see citing works

Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study

Chang, A. Y., Ayers, C. R., Minhajuddin, A., Jain, T., Nurenberg, P., de Lemos, J. A., Wild, R. A., & Auchus, R. J. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03907.x · Cited by 64 · see citing works

MANAGEMENT OF ENDOCRINE DISEASE: Morbidity in polycystic ovary syndrome.

Glintborg, D., & Andersen, M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0373 · Cited by 43 · see citing works

Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking

Luque‐Ramírez, M., Mendieta-Azcona, C., Sánchez, J. M. D. R., Maties, M., & Escobar-Morreale, H. F. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0725 · Cited by 62 · see citing works

Update on management of polycystic ovarian syndrome for dermatologists

Gainder, S., & Sharma, B. (2019) · Indian Dermatology Online Journal · doi:10.4103/idoj.idoj_249_17 · Cited by 59 · see citing works

Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits

de Melo, A. S., dos Reis, R. M., Ferriani, R. A., & Vieira, C. (2017) · Open Access Journal of Contraception · doi:10.2147/oajc.s85543 · Cited by 61 · see citing works

The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial

Pedersen, A. J. T., Stage, T. B., Glintborg, D., Andersen, M., & Christensen, M. M. H. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12874 · Cited by 54 · see citing works

Consensus statement on the use of oral contraceptive pills in polycystic ovarian syndrome women in India

Shah, D., Patil, M., & On behalf of the National PCOS Working Group (2018) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_72_18 · Cited by 51 · see citing works

Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome

Harmancı, A., Çınar, N., Bayraktar, M., & Yıldız, B. O. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04466.x · Cited by 49 · see citing works

Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis

Amiri, M., Kabir, A., Nahidi, F., Shekofteh, M., & Ramezani Tehrani, F. (2018) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2018.1435779 · Cited by 40 · see citing works

Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome

Fruzzetti, F., Perini, D., Lazzarini, V., Parrini, D., Gambacciani, M., & Genazzani, A. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.10.016 · Cited by 41 · see citing works

Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study

Manzoor, S., Ganie, M. A., Amin, S., Shah, Z. A., Bhat, I. A., Yousuf, S. D., Jeelani, H., Kawa, I. A., Fatima, Q., & Rashid, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-46644-4 · Cited by 40 · see citing works

Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome

Soares, G. M., Vieira, C. S., Martins, W. P., dos Reis, R. M., de Sá, M. F. S., & Ferriani, R. A. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01877.x · Cited by 38 · see citing works

Cardiometabolic abnormalities in the polycystic ovary syndrome: Pharmacotherapeutic insights

Westerveld, H. E., Hoogendoorn, M., de Jong, A. W. F., Goverde, A. J., Fauser, B. C. J. M., & Dallinga‐Thie, G. M. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.04.009 · Cited by 38 · see citing works

Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism

Leo, V. D., Fruzzetti, F., Musacchio, M. C., Scolaro, V., Sabatino, A. D., & Morgante, G. (2013) · Contraception · doi:10.1016/j.contraception.2012.09.003 · Cited by 37 · see citing works

Metformin improves endothelial function and carotid intima media thickness in patients with PCOS

Kaya, M. G., Yıldırım, S., Çalapkorur, B., Akpek, M., Ünlühızarcı, K., & Keleştimur, F. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1006188 · Cited by 36 · see citing works

Targeting insulin sensitivity in the treatment of polycystic ovary syndrome

Pasquali, R., & Gambineri, A. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903190699 · Cited by 35 · see citing works

Concepts of Contraception for Adolescent and Young Adult Women with Chronic Illness and Disability

Greydanus, D. E., Pratt, H. D., & Patel, D. R. (2012) · Disease-a-Month · doi:10.1016/j.disamonth.2012.02.001 · Cited by 31 · see citing works

Oral contraceptives in adolescent women

Bitzer, J. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.09.005 · Cited by 30 · see citing works

Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment

Spritzer, P. M., & Motta, A. B. (2015) · International Journal of Clinical Practice · doi:10.1111/ijcp.12719 · Cited by 30 · see citing works

Thiazolinedione treatment in PCOS – an update

Glintborg, D., & Andersen, M. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.491572 · Cited by 30 · see citing works

Nutritional and herbal interventions for polycystic ovary syndrome (PCOS): a comprehensive review of dietary approaches, macronutrient impact, and herbal medicine in management

Muhammed Saeed, A. A., Noreen, S., Awlqadr, F. H., Farooq, M. I., Qadeer, M., Rai, N., Farag, H. A., & Saeed, M. N. (2025) · Journal of Health, Population and Nutrition · doi:10.1186/s41043-025-00899-y · Cited by 29 · see citing works

Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: A randomized study

Romualdi, D., Cicco, S. D., Busacca, M., Gagliano, D., Lanzone, A., & Guido, M. (2013) · Journal of Endocrinological Investigation · doi:10.1007/bf03346756 · Cited by 26 · see citing works

Comparing the Effects of Combined Oral Contraceptives Containing Progestins With Low Androgenic and Antiandrogenic Activities on the Hypothalamic-Pituitary-Gonadal Axis in Patients With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis

Amiri, M., Tehrani, F. R., Nahidi, F., Kabir, A., & Azizi, F. (2018) · JMIR Research Protocols · doi:10.2196/resprot.9024 · Cited by 26 · see citing works

Correlations between salivary- and blood-derived gonadal hormone assessments and implications for inclusion of female participants in research studies

Huang, T., Howse, F. M., Stachenfeld, N. S., & Usselman, C. W. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00399.2022 · Cited by 26 · see citing works

Novel strategies in the management of polycystic ovary syndrome.

Spritzer, P. M., Motta, A. B., Sir‐Petermann, T., & Diamanti‐Kandarakis, E. (2015) · PubMed · Cited by 25 · see citing works

Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders

Wang, Q.-Y., Song, Y., Huang, W., Xiao, L. Y., Wang, Q., & Feng, G. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.179783 · Cited by 24 · see citing works

A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome

Mhao, N. S., Al-Hilli, A. S., Hadi, N. R., Jamil, D. A., & Al-Aubaidy, H. A. (2015) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2015.10.001 · Cited by 23 · see citing works

The bencfit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers

Christakou, C. D., Κόλλιας, Α., Piperi, C., Katsikis, I., Panidis, D., & Diamanti‐Kandarakis, E. (2014) · HORMONES · doi:10.14310/horm.2002.1553 · Cited by 22 · see citing works

The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome

Diamanti‐Kandarakis, E., Kandaraki, E., Christakou, C. D., & Panidis, D. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00588.x · Cited by 22 · see citing works

Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome

Mehrabian, F., Tehrani, H. G., Mohamadkhani, M., Moinoddini, M., & Karimzadeh, P. (2016) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.177354 · Cited by 21 · see citing works

Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women

Yousuf, S. D., Ganie, M. A., Urwat, U., Ahmad, S. M., Zargar, M. A., Dar, M. A., Manzoor-ul-Rehman, M., Mudassar, S., & Rashid, F. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02187-5 · Cited by 21 · see citing works

Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol–cyproterone acetate

Göde, F., Karagöz, Ç., Posacı, C., Saatli, B., Uysal, D., Seçil, M., & Akdeniz, B. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-010-1790-9 · Cited by 21 · see citing works

Ethinylestradiol30μg-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome?

Ilie, I. R. P., Marian, I., Mocan, T., Ilie, R., MOCAN, L. C., Duncea, I., & Pepene, C. E. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-9 · Cited by 19 · see citing works

The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment

Baldani, D. P., Skrgatic, L., Ougouag, R., & Kasum, M. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1381681 · Cited by 17 · see citing works

Polycystic Ovary Syndrome and Pelvic Floor Dysfunction: A Narrative Review

Naz, M. S. G., Tehrani, F. R., Behroozi-Lak, T., Mohammadzadeh, F., Badr, F. K., & Ozgoli, G. (2020) · Research and Reports in Urology · doi:10.2147/rru.s249611 · Cited by 16 · see citing works

Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome

Morgante, G., Cappelli, V., Troìa, L., & Leo, V. D. (2020) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2020.1736546 · Cited by 15 · see citing works

Trends in prescribing patterns of hormonal contraceptives for adolescents

O’Brien, S. H., Kaizar, E. E., Gold, M. A., & Kelleher, K. J. (2008) · Contraception · doi:10.1016/j.contraception.2007.12.009 · Cited by 14 · see citing works

Effect of l-carnitine supplementation on liver fat content and cardiometabolic indices in overweight/obese women with polycystic ovary syndrome: A randomized controlled trial

Sangouni, A. A., Sasanfar, B., Ghadiri‐Anari, A., & Hosseinzadeh, M. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.08.005 · Cited by 13 · see citing works

The effect of drospirenone (3 mg) with ethinyl estradiol (30 mcg) containing pills on ovarian blood flows in women with polycystic ovary syndrome: a case controlled study

Okyay, R. E., Göde, F., Acet, F., Bodur, T., Çağlıyan, E., Şahan, C., Posacı, C., & Gülekli, B. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.06.027 · Cited by 12 · see citing works

The effect of oral contraception on cardiometabolic risk factors in women with elevated androgen levels

Krysiak, R. G., Gilowska, M., & Okopień, B. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.09.013 · Cited by 12 · see citing works

Modulation of higher-primate adrenal androgen secretion with estrogen-alone or estrogen-plus-progesterone intervention

Conley, A. J., Stanczyk, F. Z., Morrison, J. H., Borowicz, P. P., Benirschke, K., Gee, N. A., & Lasley, B. L. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318273a070 · Cited by 12 · see citing works

Abnormal Uterine Bleeding: a Focus on Polycystic Ovary Syndrome

Hickey, M., Karthigasu, K. T., & Agarwal, S. (2009) · Women s Health · doi:10.2217/whe.09.20 · Cited by 11 · see citing works

17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities

Maier, P. S., Mattiello, S. S., Lages, L. N., & Spritzer, P. M. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.650760 · Cited by 11 · see citing works

Laser and Light-Based Therapies for Hirsutism Management in Women With Polycystic Ovarian Syndrome

Tan, K., Coster, T., Mousa, A., Mar, A., Piltonen, T., Boyle, J. A., Teede, H. J., Joham, A. E., Romualdi, D., & Tay, C. T. (2024) · JAMA Dermatology · doi:10.1001/jamadermatol.2024.0623 · Cited by 10 · see citing works

Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome

Paterakis, T., & Diamanti‐Kandarakis, E. (2014) · Current Obesity Reports · doi:10.1007/s13679-014-0127-6 · Cited by 10 · see citing works

Treatment for polycystic ovary syndrome: a critical appraisal of treatment options

Nader, S. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.3.349 · Cited by 9 · see citing works

The Role of Aromatic Amino Acids in Polycystic Ovary Syndrome through Patients’ Blood Metabolic Profiling: A Systematic Review of the Past Five Years

Gkantzos, A., Kalogiannis, S., & Deda, O. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00937 · Cited by 8 · see citing works

Mothers' attitude to the use of a combined oral contraceptive pill by their daughters for menstrual disorders or contraception

Yiu, K. W., Chan, S. S. C., & Chung, T. K. H. (2017) · Hong Kong Medical Journal · doi:10.12809/hkmj164993 · Cited by 8 · see citing works

Hirsutism in young women

Swingler, R., Awala, A., & Gordon, U. D. (2009) · The Obstetrician & Gynaecologist · doi:10.1576/toag.11.2.101.27483 · Cited by 8 · see citing works

Cardiometabolic Effects of Cabergoline and Combined Oral Contraceptive Pills in Young Women with Hyperprolactinemia: A Pilot Study

Krysiak, R. G., Kowalcze, K. E., & Okopień, B. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093208 · Cited by 6 · see citing works

A bitter pill to swallow: adjustments to oral contraceptive pill use in polycystic ovary syndrome

Calcagno, M., Serra, P., Etrusco, A., Margioula‐Siarkou, C., Terzic, S., Giannini, A., Garzon, S., Ferrari, F. G., Dellino, M., & Laganà, A. S. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2371977 · Cited by 5 · see citing works

Current procedures for managing polycystic ovary syndrome

Massicotte, M.-H., Langlois, F., & Baillargeon, J. (2009) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.09.74 · Cited by 5 · see citing works

Menstrual cyclicity post OC withdrawal in PCOS: Use of non-hormonal options

Kulshreshtha, B., Arora, A., Pahuja, I., Sharma, N., & Pant, S. (2016) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2016.1159667 · Cited by 5 · see citing works

Risk of impaired glucose tolerance in normal weight hirsute women during four years observation

Andries, M., Glintborg, D., & Andersen, M. (2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016341003801680 · Cited by 5 · see citing works

Redox-endocrine triad in PCOS: can vitamin D, myo-inositol, and melatonin synergize as bioactive cocktails?

Subakathulla, S., Manoj, N., Patanwala, A. M., Premvignesh, P. A., Alobaid, Y. M., Majie, A., Gorain, B., Dutta, S., Sengupta, P., Rosas, I. M., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1825853 · Cited by 4 · see citing works

Diet and exercise in the management of PCOS: Starting from the basics

Markantes, G. Κ., Tsichlia, G., & Georgopoulos, N. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00010-9 · Cited by 4 · see citing works

Oral contraceptives in polycystic ovarian syndrome: the long and short of it

Nader, S. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.88 · Cited by 3 · see citing works

The polycystic ovary syndrome: a position statement from the European Society of

Conway, G. S., Dewailly, D., Diamanti‐Kandarakis, E., Franks, S., Gambineri, A., Keleştimur, F., Μacut, D., Micić, D., Pasquali, R., Pfeifer, M., et al. (2014) · Cited by 3 · see citing works

Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate

Markantes, G. Κ., Saltamavros, A. D., Vervita, V., Armeni, A. K., Karela, A., Adonakis, G. L., Decavalas, G., & Georgopoulos, N. A. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.569783 · Cited by 3 · see citing works

[Efficacy and metabolic safety of long-term treatment with ethinyl oestradiol/cyproterone and desogestrel/ethinyl oestradiol tablets in women with polycystic ovary syndrome].

Zhang, J., Su, M., Xu, L., Yang, Z., Yin, W., Nie, Y., Qiao, X., Cheng, R., & Ma, Y. (2018) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-4254.2018.08.03 · Cited by 2 · see citing works

The Role of Angiogenic Factor Dysregulation in the Pathogenesis of Polycystic Ovarian Syndrome

Chen, A. Y., Seifer, D. B., & Tal, R. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_23 · Cited by 2 · see citing works

Estados hiperandrogénicos: revisión de la literatura

Villarreal-Tordecilla, G. A. (2009) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.319 · Cited by 2 · see citing works

Polycystic Ovary Syndrome: Update on Treatment Options and Treatment Considerations for the Future

Farrell-Turner, K. A. (2011) · Clinical Medicine Insights Women s Health · doi:10.4137/cmwh.s6715 · Cited by 2 · see citing works

A preliminary report comparing the effect of Asafoetida with oral contraceptive on polycystic ovarian syndrome in a double-blind randomized trial.

Dehparvar, N., Garshasbi, A., Niasari-Naslaji, A., Alijaniha, F., Fesharaki, M. G., Ghaffari, F., & Naseri, M. (2024) · PubMed Central · doi:10.22038/ajp.2023.23122 · Cited by 2 · see citing works

Drospirenone Containing Combined Oral Contraceptive Premedication before Letrozole Ovulation Induction in Clomiphene Resistant PCOS, Is it Worth the Wait?

Salama, M. S., & Hamza, H. (2019) · Gynecology & Reproductive Health · doi:10.33425/2639-9342.1080 · Cited by 2 · see citing works

Treatment of polycystic ovary syndrome: recent trial results

Ganie, M. A., Chakraborty, S., & Rehman, H. (2015) · Clinical Investigation · doi:10.4155/cli.14.133 · Cited by 1 · see citing works

Zaburzenia gospodarki węglowodanowej u kobiet z zespołem wielotorbielowatych jajników (PCOS)

Kuligowska-Jakubowska, M. (2012) · Cited by 1 · see citing works

The Polycystic Ovary Syndrome Status - A Risk Factor for Future Cardiovascular Disease

Ilie, I. R. P., Ilie, R., MOCAN, L. C., Georgescu, C. E., Duncea, I., Mocan, T., Ghibu, S., & Iancu, C. (2012) · InTech eBooks · doi:10.5772/32072 · Cited by 1 · see citing works

Adolesanda Polikistik Over Sendromu

Şahi̇n, L., & Aygün, B. (2013) · DergiPark (Istanbul University) · Cited by 1 · see citing works

Синдром поликистозных яичников. Официальное заявление Европейского общества эндокринологии

Conway, G. S., Dewailly, D., & Diamanti‐Kandarakis, E. (2015) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · doi:10.18370/2309-4117.2015.25.32-52 · Cited by 1 · see citing works

Polycystic Ovarian Syndrome: Long Term Health Risks and the Effect of Life Style Changes: Review

Arusoğlu, G., & Kaya, P. (2016) · Turkiye Klinikleri Journal of Health Sciences · doi:10.5336/healthsci.2015-45527 · Cited by 1 · see citing works

Current guidelines for the treatment of polycystic ovary syndrome: benefits of oral contraceptives with antiandrogenic progestins

Yureneva, S. V., & Ilina, L. M. (2017) · Russian Journal of Human Reproduction · doi:10.17116/repro201723456-64 · Cited by 1 · see citing works

Phenotyping of Indian Polycystic Ovarian Syndrome on the basis of Biochemical Parameters: A retrospective analysis via Hierarchical Cluster ClassificationPreprint

Janani, D. M., Ayyappan, R., & Usha, B. (2020) · medRxiv · doi:10.1101/2020.11.16.20232942 · Cited by 1 · see citing works

Contraception des cas particuliers

Serfaty, D. (2011) · Elsevier eBooks · doi:10.1016/b978-2-294-70921-0.00013-9

Use of oral contraceptives in the treatment of women with polycystic ovary syndrome

Stovall, D. W., Menke, M., Springel, E. H., Jarvis, A., & Karjane, N. W. (2007) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.2.3.347

Metaboliczne konsekwencje stosowanych obecnie form farmakoterapii kobiet z zespołem wielotorbielowatych jajników

Dardzińska, J. A., & Rachoń, D. (2012) · Endokrynologia, Otyłość i Zaburzenia Przemiany Materii

GDAŃSKI UNIWERSYTET MEDYCZNY

Renke, M. (2009)

Unravelling the link between insulin resistance and androgen excess

O’Reilly, M. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)

Oral contraceptives: indications and cautions

Nader, S. (2013) · doi:10.2217/ebo.12.238

EFFICACY OF ACNE THERAPY IN PATIENTS WITH OVARIAN HYPERANDROGENISM

О.Б., К., Tezikov, Y. V., Lipatov, I. S., & Аравина, О. Р. (2021) · Медико-фармацевтический журнал «Пульс» · doi:10.26787/nydha-2686-6838-2021-23-6-35-42

Η επίδραση της αντισυλληπτικής αγωγής στους γενετικούς, αγγειακούς, βιοχημικούς και ορμονικούς πρώιμους δείκτες αυξημένου κινδύνου σε νέες γυναίκες με σύνδρομο πολυκυστικών ωοθηκών (PCOS)

Markantes, G. Κ. (2013) · doi:10.12681/eadd/36878

OPINION Polycystic ovary syndrome, oral contraceptives and metabolic issues: new

(2015)

Chronic Treatment of Polycystic Ovary Syndrome

Nader, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_9 · Cited by 2 · see citing works

Metabolic Effects of Combined Hormonal Contraception and Its Use in Polycystic Ovary Syndrome

Awad, D. V. (2026) · Reproductive medicine for clinicians · doi:10.1007/978-3-032-07322-8_14

Oral Contraceptives in Polycystic Ovary Syndrome: Risk-Benefit Assessment

Yıldız, B. O. (2008) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-992931 · Cited by 51 · see citing works

Oral contraceptives in polycystic ovary syndrome.

Helvacı, N., & Yıldız, B. O. (2014) · PubMed · Cited by 18 · see citing works